Literature DB >> 28509970

Testis cancer: some problems still remain unsolved.

Peter Albers1, Carsten Bokemeyer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28509970     DOI： 10.1007/s00345-017-2041-5

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  5 in total

Review 1.  Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy.

Authors:  Daniel M Berney; Leendert H J Looijenga; Muhammad Idrees; J Wolter Oosterhuis; Ewa Rajpert-De Meyts; Thomas M Ulbright; Niels E Skakkebaek
Journal:  Histopathology       Date:  2016-04-12       Impact factor: 5.087

2.  Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.

Authors:  Anja Lorch; Caroline Bascoul-Mollevi; Andrew Kramar; Lawrence Einhorn; Andrea Necchi; Christophe Massard; Ugo De Giorgi; Aude Fléchon; Kim Margolin; Jean-Pierre Lotz; Jose Ramon Germà-Lluch; Thomas Powles; Christian Kollmannsberger; Jörg Beyer
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

3.  Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer.

Authors:  Kevin M Wymer; Shane M Pearce; Kelly T Harris; Phillip M Pierorazio; Siamak Daneshmand; Scott E Eggener
Journal:  J Urol       Date:  2016-09-20       Impact factor: 7.450

Review 4.  New insights into the pathology and molecular biology of human germ cell tumors.

Authors:  Friedemann Honecker; J Wolter Oosterhuis; Frank Mayer; Jörg Thomas Hartmann; Carsten Bokemeyer; Leendert H J Looijenga
Journal:  World J Urol       Date:  2004-03-20       Impact factor: 4.226

5.  The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo.

Authors:  Sina Jostes; Daniel Nettersheim; Martin Fellermeyer; Simon Schneider; François Hafezi; Friedemann Honecker; Valerie Schumacher; Matthias Geyer; Glen Kristiansen; Hubert Schorle
Journal:  J Cell Mol Med       Date:  2016-12-27       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.